However, until few years ago, the poor knowledge regarding the β3-AR distribution and pharmacology, and the lack of selective tools suitable for the study of this β-AR subtype, has made difficult to clarify its contribution in the complex landscape of tumor biology. This evidence concerns the gene ADRB2 and neoplasm.